Affidea expands in Italy through the acquisition of two new outpatient medical centers
Affidea, the largest European provider of diagnostic imaging, outpatient and cancer care services continues to invest in the Italian market and has today announced the 100% acquisition of Medical Sport Center and Medical Center, two flagship medical centers in Lodi, Lombardy region, a densely populated area of 230.000 inhabitants.
This transaction is the 20th in the last two years made by Affidea Group in alignment with a successful growth strategy consolidating its leadership position across 15 countries in Europe.
Medical Center was founded 37 years ago with the aim of building a reputed outpatient clinic, with a wide variety of consultations, outpatient day-time surgery and gym rehabilitation. The center is well-known as a cutting-edge outstanding one-stop-shop for patients’ medical needs.
The Medical Sport Center was founded 25 years, becoming the reference point for all people passionate about sport activities or regular physical activity to improve their health condition. The medical facility offers a wide variety of services for both competitive and non-competitive sport certification. Therefore, many local sport clubs have chosen Medical Sport Center as their preferred healthcare provider for the regular check-ups of their athletes.
The two medical centers complement well Centro Radiologico Lodigiano, acquired by Affidea earlier this year, in July 2021. The deals were concluded as a result of a private negotiation where Affidea’s international reputation as a trusted business partner and high quality medical provider, was the key catalyst for securing the transaction. This investment strengthens Affidea’s presence in Lombardy region – with the Affidea network in Italy growing now to 57 medical centers, serving more than 2.3 million patients per year with more than 2500 professionals.
These acquisitions prove, once more, that Italy remains a key market for Affidea, with high ambitions to expand its range of outpatient medical services and create synergies with its existing portfolio of services which will set Affidea as the preferred healthcare provider for individuals, corporations, private health insurers, and NHS.
Giuseppe Recchi, Affidea CEO, said on the Affidea’s latest investment in Italy: “These two acquisitions are aligned with our strategic vision to create a strong European healthcare platform, that has now resched the outstanding number of 314 centers. In the last 2 years we have achieved a growth record despite the COVID pandemic and we are set for further expansion partnering with best-in-class diagnostic imaging and outpatient operators to offer our patients the best medical services that can respond to their prevention and medical needs.
We are working with more than 9000 healthcare professionals in our network, serving over 10 million patients per year. With a diversified range of services, the best medical professionals and a wide footprint across Europe, Affidea is uniquely positioned to lead the expansion on integrated care, having a robust platform and business model capable of creating value in a multinational environment. Only this year, we have successfuly completed 9 acquisitions, adding 45 new centers in 4 countries, consolidating our European leadership to a total of 314 centers. We have a strong appetite for continued growth and we will continue to further look for investment opportunities, creating value for patients, doctors and payors across Europe”.
Commenting on the acquisition, Fabio Silo, Country Manager of Affidea Italy, added: "With this acquisition, we are adding new outpatient capabilities and adjacent services, synergetic with the other Affidea centers, which will allow us to offer a larger access for patients to best-in-class integrated services at the highest standards of quality and safety. In the last 3 years, we have built a strong healthcare provider across Italy, with an impressive network of centers, delivering outstanding care to our patients, and we have strong ambitions to further continue our development in the country. It is with great pride that I welcome all Medical Center and Medical Sport Center teams into Affidea and I am looking forward to working closely with them as one team with one core mission: improving millions of lives every year”.
These latest two investments bring Affidea to 9 successfully completed acquisitions in the last year. Only in Italy, the company added 35 new centers this year, with the acquisition of Gruppo CDC, announced in June 2021, followed by CRL in July and Medical Center and Medical Sports Center today. The company also expanded in Spain, with the acquisition of Medicentro, in October, and Gamma Clinica, in January. Northern Ireland was a third country where Affidea expanded in 2021 with the acquisition of Orthoderm in March, and Hillsborough clinic in October. Last, but not least, 2021 was the year when Affidea entered UK, with the acquisition of Fortius clinic, the renowned provider specialised in orthopaedics and sports medicine.